GENOCEA BIOSCIENCES INC's ticker is GNCA and the CUSIP is 372427401. A total of 43 filers reported holding GENOCEA BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,969,000 | +7.8% | 1,574,979 | +0.0% | 0.00% | – |
| Q4 2021 | $1,827,000 | -39.1% | 1,574,879 | +0.8% | 0.00% | – |
| Q3 2021 | $3,001,000 | -16.6% | 1,563,101 | +1.6% | 0.00% | – |
| Q2 2021 | $3,600,000 | -17.8% | 1,538,463 | -4.9% | 0.00% | – |
| Q1 2021 | $4,382,000 | +12.4% | 1,617,044 | +0.4% | 0.00% | – |
| Q4 2020 | $3,898,000 | +5.2% | 1,610,826 | -0.5% | 0.00% | – |
| Q3 2020 | $3,707,000 | +105.6% | 1,618,686 | +106.5% | 0.00% | – |
| Q2 2020 | $1,803,000 | +35.9% | 783,968 | +1.6% | 0.00% | – |
| Q1 2020 | $1,327,000 | -17.0% | 771,422 | -0.1% | 0.00% | – |
| Q4 2019 | $1,598,000 | -28.6% | 771,922 | 0.0% | 0.00% | – |
| Q3 2019 | $2,238,000 | -24.0% | 771,922 | +2.7% | 0.00% | – |
| Q2 2019 | $2,946,000 | – | 751,377 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 375,000 | $435,000 | 25.16% |
| COMMODORE CAPITAL LP | 3,079,756 | $3,573,000 | 0.83% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,972,056 | $2,288,000 | 0.26% |
| NEA Management Company, LLC | 10,376,936 | $12,037,000 | 0.24% |
| BVF INC/IL | 4,012,404 | $4,654,000 | 0.17% |
| Avoro Capital Advisors LLC | 5,084,184 | $5,898,000 | 0.10% |
| Boxer Capital, LLC | 1,134,453 | $1,316,000 | 0.05% |
| Ikarian Capital, LLC | 196,821 | $228,000 | 0.03% |
| Empirical Asset Management, LLC | 10,000 | $12,000 | 0.01% |
| Point72 Asset Management, L.P. | 2,652,974 | $3,077,000 | 0.01% |